Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

CytoDyn Operating Margin 2010-2025 | CYDY

Current and historical operating margin for CytoDyn (CYDY) over the last 10 years. The current operating profit margin for CytoDyn as of February 28, 2025 is 0.00%.
  
CytoDyn Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-05-31 $0.00B $-0.15B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.357B $0.000B
CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several months of interruption from conventional drug therapy.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.499B 30.20
Zoetis (ZTS) United States $70.868B 26.44
Takeda Pharmaceutical (TAK) Japan $48.811B 9.71
Daiichi Sankyo, - (DSNKY) Japan $42.149B 21.60
BeOne Medicines - (ONC) Cayman Islands $26.906B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.786B 0.00
Summit Therapeutics (SMMT) United States $18.232B 0.00
Merck (MKKGY) Germany $16.850B 12.35
Shionogi (SGIOY) Japan $14.717B 14.74
United Therapeutics (UTHR) United States $13.283B 11.75
Neurocrine Biosciences (NBIX) United States $12.777B 43.77
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Ionis Pharmaceuticals (IONS) United States $6.844B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.636B 0.00
Grifols, S.A (GRFS) Spain $6.243B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.367B 0.00
Hypermarcas (HYPMY) Brazil $3.183B 20.94
Crinetics Pharmaceuticals (CRNX) United States $2.790B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.639B 14.27
Catalyst Pharmaceuticals (CPRX) United States $2.618B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.229B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.879B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.871B 0.00
ARS Pharmaceuticals (SPRY) United States $1.622B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.532B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.320B 0.00
Harrow (HROW) United States $1.165B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.025B 20.51
Ardelyx (ARDX) United States $1.022B 0.00
Enliven Therapeutics (ELVN) United States $1.017B 0.00
Verve Therapeutics (VERV) United States $1.006B 0.00
Dyne Therapeutics (DYN) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.975B 5.26
Akebia Therapeutics (AKBA) United States $0.951B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.864B 0.00
Cronos Group (CRON) Canada $0.787B 0.00
Xeris Biopharma Holdings (XERS) United States $0.743B 0.00
Elite Pharmaceuticals (ELTP) United States $0.640B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
USANA Health Sciences (USNA) United States $0.610B 13.27
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.596B 0.00
Bioventus (BVS) United States $0.577B 14.62
Amylyx Pharmaceuticals (AMLX) United States $0.562B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
Organogenesis (ORGO) United States $0.539B 0.00
Zevra Therapeutics (ZVRA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.478B 9.99
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.422B 0.00
AleAnna (ANNA) United States $0.420B 0.00
Altimmune (ALT) United States $0.386B 0.00
Savara (SVRA) United States $0.379B 0.00
Aquestive Therapeutics (AQST) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Heron Therapeutics (HRTX) United States $0.336B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.42
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.258B 0.00
OmniAb (OABI) United States $0.236B 0.00
Liminatus Pharma (LIMN) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
China SXT Pharmaceuticals (SXTC) China $0.218B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
ProKidney (PROK) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.143B 0.00
Avita Medical (RCEL) United States $0.143B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Galectin Therapeutics (GALT) United States $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Nutriband (NTRB) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.106B 17.45
VAXART, INC (VXRT) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Achieve Life Sciences (ACHV) Canada $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 35.00
ElectroCore (ECOR) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
FibroGen (FGEN) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.01
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
SciSparc (SPRC) Israel $0.000B 0.00